funding-eu EU Horizon Europe HORIZON-HLTH-2027-01 HORIZON-HLTH-2027-01-DISEASE-06 Clinical development, Phase I Clinical trials Dengue Development of monoclonal antibodies to prevent and treat infections from Flaviviruses EU — Italia · scadenza 13/04/2027
